AsnI: A novel class II restriction endonuclease from Arthrobacter sp., strain N-CM, recognizing 5′-AT/TAAT-3′

AbstractA new class II restriction endonuclease, AsnI, with a novel sequence specificity was isolated from the Gram-positive eubacterium Arthrobacter species, strain N-CM. AsnI recognizes the unambiguously defined palindromic hexanucleotide consisting of A- and T-residues. The novel enzyme in the presence of Mg2+ cleaves specifically both strands as indicated by the arrows. The staggered cuts generate 5′-protruding ends with single-stranded 5′-TA-3′ dinucleotide extensions. The novel enzyme may be a useful tool for cloning experiments by complementation of the few enzymes such as PstI and PvuI cutting only once in the Ampr-gene of plasmids pBR322 and pBR328

Геофизический прогноз нового перспективного участка в партизанском золоторудном узле (Енисейский кряж)

Рассматривается обоснование аэрогеофизических признаков золото-сульфидно-вкрапленного оруденения на новом участке в Партизанском рудном узле -Подголечном, предположительно аналогичного месторождению Благодатному Северо-Енисейского района (Енисейский кряж), по результатам съемки 2012 г. (магнитометрия, электроразведка ДИП-А, гамма-спектрометрия) масштаба 1:10000

A high-throughput test to detect C.E.R.A. doping in blood

C.E.R.A., a continuous erythropoietin receptor activator, is a new third-generation erythropoiesis-stimulating agent (ESA) that has recently been linked with abuse in endurance sports. In order to combat this new form of doping, we examined an enzyme-linked immunosorbent assay (ELISA) designed to detect the presence of C.E.R.A. in serum samples. The performance of the assay was evaluated using a pilot excretion study that involved six subjects receiving C.E.R.A. Validation data demonstrated an excellent reproducibility and ensured the applicability of the assay for anti-doping purposes. To maximize the chances of detecting the drug in serum samples, we propose the use of this specific ELISA test as a high-throughput screening method, combined with a classic isoelectric focusing test as a confirmatory assay. This strategy should make C.E.R.A. abuse relatively easy to detect, thereby preventing the future use of this drug as a doping agent